Perhexiline therapy in patients with Hypertrophic Cardiomyopathy
- Conditions
- Hypertrophic Cardiomyopathy
- Registration Number
- EUCTR2005-000755-15-GB
- Lead Sponsor
- niversity Hospital of Birmingham Foundation Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Symptomatic non-obstructive hypertrophic cardiomyopathy patients with less than 70% of predicted peak Vo2 and in sinus rhythm
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Abnormal liver function test, Pre-existing peripheral neuropathy, Concomitant use of amiodarone and women of childbearing potential .
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method